Clinical Trial Update: Response-adapted Total Neoadjuvant Therapy Guided by Induction Chemotherapy in Early- and Intermediate-risk Low Rectal Cancer for Implementation of a Watch-and-wait Strategy

View source ↗

Summary

This clinical trial evaluates response-adapted total neoadjuvant therapy guided by induction chemotherapy for early- and intermediate-risk low rectal cancer to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: West China Hospital | Conditions: Rectal Cancer | Status: RECRUITING